Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Quarterly results
Director departure
Appointed director
|
|
CorMedix Inc. (CRMD)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/17/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 06/30/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"UNDERWRITING AGREEMENT DATED JUNE 28, 2023",
"FORM OF PRE-FUNDED WARRANT",
"OPINION OF MORGAN, LEWIS & BOCKIUS LLP",
"CORMEDIX INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS Berkeley Heights, NJ – June 28, 2023 – CorMedix Inc. , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced that it intends to offer and sell shares of its common stock, and in lieu of common stock to certain investors that so chose, pre-funded warrants to purchase shares of its common stock, in an underwritten public offering. All of the shares and pre-funded warrants to be sold in the offering will be offered by CorMedix. In addition, CorMedix intends to grant the underwriters a 30-day option to purchase up to an additional 15% of shares of its common stock offered in th..." |
|
| 06/30/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 06/28/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/19/2023 |
4
| Kaplan Myron (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 6,000 shares
@ $4.543, valued at
$27.3k
|
|
| 05/18/2023 |
4/A
| Costa Paulo F (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 10,000 shares
@ $4.65, valued at
$46.5k
|
|
| 05/18/2023 |
4/A
| DUNTON ALAN W (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 3,000 shares
@ $4.3266, valued at
$13k
|
|
| 05/18/2023 |
4/A
| Stewart Robert A (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 10,000 shares
@ $4.3735, valued at
$43.7k
|
|
| 05/18/2023 |
4/A
| Todisco Joseph (CEO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Bought 5,000 shares
@ $4.58, valued at
$22.9k
|
|
| 05/17/2023 |
4
| Costa Paulo F (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 10,000 shares
@ $4.65, valued at
$46.5k
|
|
| 05/17/2023 |
4
| DUNTON ALAN W (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 3,000 shares
@ $4.3266, valued at
$13k
|
|
| 05/17/2023 |
4
| Stewart Robert A (Director) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 10,000 shares
@ $4.3735, valued at
$43.7k
|
|
| 05/17/2023 |
4
| Todisco Joseph (CEO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Granted 5,000 shares
@ $4.58, valued at
$22.9k
|
|
| 05/16/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/12/2023 |
4
| Todisco Joseph (CEO) has filed a Form 4 on CorMedix Inc.|
Txns:
| Paid exercise price by delivering 37,443 shares
@ $5.3, valued at
$198.4k
|
|
| 04/26/2023 |
8-K
| Quarterly results |
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 04/17/2023 |
8-K
| Quarterly results |
| 03/30/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/30/2023 |
8-K
| Quarterly results |
| 03/03/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/20/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|